FDA grants marketing authorization to Fujirebio's diagnostic test for Alzheimer's disease
May 06, 2022 at 14:00 PM EDT
The company said the product will be the first in vitro diagnostic test available in the United States to aid in the evaluation of patients for Alzheimer's.
